Article Details

Long-Term Data Show Favorable Survival Outcomes With G-Clb in Treatment-Naive CLL

Retrieved on: 2025-05-01 21:25:47

Tags for this article:

Click the tags to see associated articles and topics

Long-Term Data Show Favorable Survival Outcomes With G-Clb in Treatment-Naive CLL. View article details on hiswai:

Excerpt

... monoclonal antibodies, such as obinutuzumab, remain an important component of newer treatment combinations. Read more. Chronic Lymphocytic Leukemia ...

Article found on: www.ajmc.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo